Clinical characteristics of hereditary multiple exostoses: A retrospective study of mainland chinese cases in recent 23 years

Abstract

Hereditary multiple exostoses (HME) are an autosomal dominant skeletal disease with wide variations in clinical manifestations among different ethnic groups. This study investigated the epidemiology, clinical presentations, pathogenetic features and treatment strategies of HME in mainland China. We searched and reviewed the related cases published since 1990 by searching electronic databases, namely SinoMed database, Wanfang database, CNKI, Web of Science and PubMed as well as Google search engines. A total of 1051 cases of HME (male-to-female ratio 1.5:1) were investigated and the diagnosis was made in 83% before the age of 10 years. Approximately 96% patients had a family history. Long bones, ribs, scapula and pelvis were the frequently affected sites. Most patients were asymptomatic with multiple palpable masses. Common complications included angular deformities, impingement on neighbouring tissues and impaired articular function. Chondrosarcomas transformation occurred in 2% Chinese cases. Among the cases examined, about 18% had mutations in EXT1 and 28% in EXT2. Frameshift, nonsense and missense mutations represented the majority of HME-causing mutations. Diagnosis of HME was made based on the clinical presentations and radiological documentations. Most patients needed no treatment. Surgical treatment was often directed to remove symptomatic exostoses, particularly those of suspected malignancy degeneration, and correction of skeletal deformities. This study shows some variance from current literature regarding other ethnic populations and may provide valuable baseline assessment of the natural history of HME in mainland China.

Keywords

EXT1 / EXT2 / epidemiology / hereditary multiple exostoses / osteochondromas

References

[1] HennekamRC. Hereditary multiple exostoses. J Med Genet, 1991, 28(4): 262-266

[2] StieberJR, DormansJP. Manifestations of hereditary multiple exostoses. J Am Acad Orthop Surg, 2005, 13(2): 110-120

[3] BoveeJV. Multiple osteochondromas. Orphanet J Rare Dis, 2008, 3: 3-10

[4] Legeai-MalletL, MunnichA, MaroteauxP, et al.. Incomplete penetrance and expressivity skewing in hereditary multiple exostoses. Clin Genet, 1997, 52(1): 12-16

[5] WicklundCL, PauliRM, JohnstonD, et al.. Natural history study of hereditary multiple exostoses. Am J Med Genet, 1995, 55(1): 43-46

[6] PannierS. Hereditary multiple exostoses and enchondromatosis. Best Pract Res Clin Rheumatol, 2008, 22: 45-54

[7] SaglikY, AltayM, UnalVS, et al.. Manifestations and management of osteochondromas: a retrospective analysis of 382 patients. Acta Orthop Belg, 2006, 72(6): 748-755

[8] WuytsW, Van HulW, WautersJ, et al.. Positional cloning of a gene involved in hereditary multiple exostoses. Hum Mol Genet, 1996, 5(10): 1547-1557

[9] JennesI, PedriniE, ZuntiniM, et al.. Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb). Hum Mutat, 2009, 30: 1620-1627

[10] Legeai-MalletL, Margaritte-JeanninP, LemdaniM, et al.. An extension of the admixture test for the study of genetic heterogeneity in hereditary multiple exostoses. Hum Genet, 1997, 99(3): 298-302

[11] Van HulW, WuytsW, HendrickxJ, et al.. Identification of a third EXT-like gene (EXTL3) belonging to the EXT gene family. Genomics, 1998, 47(2): 230-237

[12] WuytsW, Van HulW. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes. Hum Mutat, 2000, 15(3): 220-227

[13] ZhangF, LiangJ, GuoX, et al.. Exome sequencing and functional analysis identifies a novel mutation in EXT1 gene that causes multiple osteochondromas. PLoS One, 2013, 8(8): e72316

[14] KobayashiS, MorimotoK, ShimizuT, et al.. Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus. Biochem Biophys Res Commun, 2000, 268: 860-867

[15] YangL, HuiWS, ChanWC, et al.. A splice-site mutation leads to haploinsufficiency of EXT2 mRNA for a dominant trait in a large family with multiple osteochondromas. J Orthop Res, 2010, 28(11): 1522-1530

[16] XuL, XiaJ, JiangH, et al.. Mutation analysis of hereditary multiple exostoses in the Chinese. Hum Genet, 1999, 105(1–2): 45-50

[17] SekiH, KubotaT, IkegawaS, et al.. Mutation frequencies of EXT1 and EXT2 in 43 Japanese families with hereditary multiple exostoses. Am J Med Genet, 2001, 99(1): 59-62

[18] KitsoulisP, GalaniV, StefanakiK, et al.. Osteochondromas: review of the clinical, radiological and pathological features. In Vivo, 2008, 22: 633-646

[19] NoonanKJ, FeinbergJR, LevendaA, et al.. Natural history of multiple hereditary osteochondromatosis of the lower extremity and ankle. J Pediatr Orthop, 2002, 22(1): 120-124

[20] AssefaD, MurphyRC, BergmanK, et al.. Three faces of costal exostoses: case series and review of literature. Pediatr Emerg Care, 2011, 27(12): 1188-1191

[21] MurpheyMD, ChoiJJ, KransdorfMJ, et al.. Imaging of osteochondroma: variants and complications with radiologic-pathologic correlation. Radiographics, 2000, 20: 1407-1434

[22] PedriniE, JennesI, TremosiniM, et al.. Genotypephenotype correlation study in 529 patients with multiple hereditary exostoses: identification of “protective” and “risk” factors. J Bone Joint Surg Am, 2011, 93(24): 2294-2302

[23] PeiY, WangY, HuangW, et al.. Novel mutations of EXT1 and EXT2 genes among families and sporadic cases with multiple exostoses. Genet Test Mol Biomarkers, 2010, 14(6): 865-872

[24] PorterDE, LonieL, FraserM, et al.. Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study. J Bone Joint Surg Br, 2004, 86(7): 1041-1046

[25] ZhuHY, HuYL, YangY, et al.. Mutation analysis and prenatal diagnosis of EXT1 gene mutations in Chinese patients with multiple osteochondromas. Chin Med J (Engl), 2011, 124(19): 3054-3057

[26] JonesK. Glycobiology and the growth plate: current concepts in multiple hereditary exostoses. J Pediatr Orthop, 2011, 31(5): 577-586

[27] Trebicz-GeffenM, RobinsonD, EvronZ, et al.. The molecular and cellular basis of exostosis formation in hereditary multiple exostoses. Int J Exp Pathol, 2008, 89(5): 321-331

[28] ShahZK, PehWC, WongY, et al.. Sarcomatous transformation in diaphyseal aclasis. Australas Radiol, 2007, 51(2): 110-119

[29] GeirnaerdtMJ, HogendoornPC, BloemJL, et al.. Cartilaginous tumors: fast contrast-enhanced MR imaging. Radiology, 2000, 214(2): 539-546

[30] IpD, LiYH, ChowW, et al.. Reconstruction of forearm deformities in multiple cartilaginous exostoses. J Pediatr Orthop B, 2003, 12(1): 17-21

[31] LeeKC, DaviesAM, Cassar-PullicinoVN. Imaging the complications of osteochondromas. Clin Radiol, 2002, 57(1): 18-28

[32] EvansHL, AyalaAG, RomsdahlMM. Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer, 1977, 40(2): 818-831

[33] PataG, NascimbeniR, DiLD, et al.. Hereditary multiple exostoses and juvenile colon carcinoma: A case with a common genetic background?. J Surg Oncol, 2009, 100: 520-522